CAH supply chain intelligence for Cardinal Health, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Cardinal Health, Inc. (CAH) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| CHRS | Coherus Oncology, Inc. | 95% | Reciprocal relationship from CHRS graph: Reciprocal relationship from CAH graph: Reciprocal relationship from CHRS graph: e employees, effective March 10, 2023 for most of these employees. In the fir… |
| MASI | Masimo Corporation | 95% | Reciprocal relationship from MASI graph: outstanding shares of the Company. The Vice Chairman of the Company’s board of directors, Quentin Koffey, also serves as Chief Investment Officer of Politan. … |
| ADCT | ADC Therapeutics SA | 92% | Reciprocal relationship from ADCT graph: Reciprocal relationship from CAH graph: Reciprocal relationship from ADCT graph: Reciprocal relationship from CAH graph: Reciprocal relationship from ADCT gra… |
| AMPH | Amphastar Pharmaceuticals, Inc. | 90% | Reciprocal relationship from AMPH graph: al. ANP currently manufactures heparin sodium for our enoxaparin product, isoproterenol, hyaluronidase, and medroxyprogesterone for Amphastar’s current produc… |
| APT | Alpha Pro Tech, Ltd. | 85% | Reciprocal relationship from APT graph: Owens Corning and GAF for synthetic roof underlayment. Our major competitor in the medical and dental markets is Kimberly-Clark Corporation of Fort Worth, Texa… |
| GILD | Gilead Sciences, Inc. | 85% | Reciprocal relationship from GILD graph: Reciprocal relationship from CAH graph: Reciprocal relationship from GILD graph: Reciprocal relationship from CAH graph: Reciprocal relationship from GILD gra… |
| JAGX | Jaguar Health, Inc. | 85% | Reciprocal relationship from JAGX graph: Reciprocal relationship from CAH graph: Reciprocal relationship from JAGX graph: s promise to transfer Mytesi to specialty pharmacies based on specified payme… |
| MGNX | MacroGenics, Inc. | 85% | Reciprocal relationship from MGNX graph: Reciprocal relationship from CAH graph: Reciprocal relationship from MGNX graph: Reciprocal relationship from CAH graph: Reciprocal relationship from MGNX gra… |
| RIGL | Rigel Pharmaceuticals, Inc. | 85% | Reciprocal relationship from RIGL graph: ivable (as it relates to allowance for prompt pay discount) and prepaid and other current assets (as it relates to certain chargebacks and other fees that wer… |
| ARDX | Ardelyx, Inc. | 72% | Reciprocal relationship from ARDX graph: NOTE 4. INVENTORY Inventory consisted of the following: (in thousands) March 31, 2026 December 31, 2025 Raw materials $ 27,941 $ 28,009 Work in process 90,043… |
| COR | Cencora, Inc. | 72% | Reciprocal relationship from COR graph: sed to manage the majority of its transactional volume. The warehouse operating systems have improved U.S. Healthcare Solutions’ productivity and operating lev… |
| CVS | CVS Health Corporation | 72% | Reciprocal relationship from CVS graph: Reciprocal relationship from CAH graph: Reciprocal relationship from CVS graph: Reciprocal relationship from CAH graph: Reciprocal relationship from CVS graph:… |
| EMMA | Emmaus Life Sciences, Inc. | 72% | Reciprocal relationship from EMMA graph: in, dyspepsia, burning sensation, and hot flash. Commercialization and Distribution United States Until August 2024, Endari® was marketed and sold in the U.S.… |
| GRDN | Guardian Pharmacy Services, Inc. | 72% | Reciprocal relationship from GRDN graph: Reciprocal relationship from CAH graph: Reciprocal relationship from GRDN graph: Reciprocal relationship from CAH graph: Reciprocal relationship from GRDN gra… |
| HRMY | Harmony Biosciences Holdings, Inc. | 72% | Reciprocal relationship from HRMY graph: Reciprocal relationship from CAH graph: Reciprocal relationship from HRMY graph: (“API”). ● Corden Pharma Chenôve SAS, a full-service contract development and… |
| HROW | Harrow, Inc. | 72% | Reciprocal relationship from HROW graph: Reciprocal relationship from CAH graph: Reciprocal relationship from HROW graph: Reciprocal relationship from CAH graph: Reciprocal relationship from HROW gra… |
| LLY | Eli Lilly and Company | 72% | Reciprocal relationship from LLY graph: Reciprocal relationship from CAH graph: Reciprocal relationship from LLY graph: ng at medical meetings. In addition, we advertise certain products directly to … |
| MCK | McKesson Corporation | 72% | Reciprocal relationship from MCK graph: Reciprocal relationship from CAH graph: Reciprocal relationship from MCK graph: nternational, national, regional, and local full-line, short-line, and specialt… |
| MRK | Merck & Co., Inc. | 72% | Reciprocal relationship from MRK graph: . Includes cumulative translation adjustments. Amount in 2025 includes the reversal of $ million for a Zerbaxa (ceftolozane and tazobactam) sales-based milesto… |
| PCRX | Pacira BioSciences, Inc. | 72% | Reciprocal relationship from PCRX graph: s of the partnership, LG Chem has the exclusive rights to commercialize EXPAREL in the region. We received a $2.0 million upfront payment that we will recogni… |
| PFE | Pfizer Inc. | 72% | Reciprocal relationship from PFE graph: ed with sales recorded in 2022, related to the expected return of an estimated million treatment courses of EUA-labeled U.S. government inventory. In the first… |
| SNYNF | Sanofi | 72% | Reciprocal relationship from SNYNF graph: Reciprocal relationship from CAH graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from CAH graph: Reciprocal relationship from SNYNF … |
| SNYNF | Sanofi | 72% | . This growth is driven by robust demand across specialty distribution, the expansion of the company’s MSO platforms and over 30% anticipated revenue growth in BioPharma Solutions in fiscal 2026. In … |
| SUPN | Supernus Pharmaceuticals, Inc. | 72% | Reciprocal relationship from SUPN graph: could be harmed. The majority of our product sales are to pharmaceutical wholesalers, specialty pharmacies, and distributors who, in turn, sell our products t… |
| VTRS | Viatris Inc. | 72% | Reciprocal relationship from VTRS graph: posal & impairment charges ( ) Impairment of goodwill ( ) Research and development ( ) Acquired IPR&D ( ) Litigation settlements and other contingencies, net … |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| USGOV-DEPARTMENT-OF-DEFENSE | USGOV-DEPARTMENT-OF-DEFENSE | 95% | USAspending awards from Department of Defense: $901,503 across 3 awards. SPE2DU26F0Y26 4570886442!PHARM PRIME VENDOR FLEET; SPE2DU26F0H27 4570188256!PHARM PRIME VENDOR FLEET; SPE2DX25FQNQU 4568214610… |
| USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES | USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES | 95% | USAspending awards from Department of Health and Human Services: $231,198 across 1 awards. 75N90025P00449 SIRTURO (BEDAQUILINE) DRUG TABLETS FROM CARDINAL HEALTH 108, LLC:1296676 [25-000022] | Qwen c… |
| USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | 95% | USAspending awards from Department of Veterans Affairs: $2,994,125 across 6 awards. 36C24624P0018 RADIOPHARMACEUTICALS; 36C24720N0437 RADIOPHARMACEUTICAL ISOTOPES FUNDING DOCUMENT; 36C24123P0019 VARI… |
| GRDN | Guardian Pharmacy Services, Inc. | 92% | Reciprocal relationship from GRDN graph: Reciprocal relationship from CAH graph: Reciprocal relationship from GRDN graph: a “distinct pharmacy setting” and requires payors to compensate designated lo… |
| HRMY | Harmony Biosciences Holdings, Inc. | 92% | Reciprocal relationship from HRMY graph: (“API”). ● Corden Pharma Chenôve SAS, a full-service contract development and manufacturing organization (“CDMO”) manufactures our API. ● Procos, S.p.A. opera… |
| EXISTING-CUSTOMERS | EXISTING-CUSTOMERS | 90% | Pharma segment revenue for the three months ended March 31, 2026 increased 11 percent to $56.1 billion from the comparative prior-year quarter, primarily due to branded and specialty pharmaceutical s… |
| NEW-CUSTOMERS | NEW-CUSTOMERS | 90% | Pharma segment revenue for the nine months ended March 31, 2026 increased 18 percent to $176.0 billion from the comparative prior-year period, primarily due to branded and specialty pharmaceutical sa… |
| CVS | CVS Health Corporation | 85% | Reciprocal relationship from CVS graph: Reciprocal relationship from CAH graph: Reciprocal relationship from CVS graph: Reciprocal relationship from CAH graph: Reciprocal relationship from CVS graph:… |
| CVS | CVS Health Corporation | 85% | ability to meet demand may be impacted by supply constraints. Additionally, the recently issued Executive Order titled “Delivering Most-Favored Nation Prescription Drug Pricing to American Patients” … |
| AMBULATORY-SURGERY-CENTERS | AMBULATORY-SURGERY-CENTERS | 80% | distribute medical products to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. |
| CLINICAL-LABORATORIES | CLINICAL-LABORATORIES | 80% | distribute medical products to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. |
| HOSPITALS | HOSPITALS | 80% | distribute medical products to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. |
| OTHER-HEALTHCARE-PROVIDERS | OTHER-HEALTHCARE-PROVIDERS | 80% | distribute medical products to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. |
| AMPH | Amphastar Pharmaceuticals, Inc. | 72% | Reciprocal relationship from AMPH graph: al. ANP currently manufactures heparin sodium for our enoxaparin product, isoproterenol, hyaluronidase, and medroxyprogesterone for Amphastar’s current produc… |
| APT | Alpha Pro Tech, Ltd. | 72% | Reciprocal relationship from APT graph: Reciprocal relationship from CAH graph: Reciprocal relationship from APT graph: Reciprocal relationship from CAH graph: Reciprocal relationship from APT graph:… |
| ARDX | Ardelyx, Inc. | 72% | Reciprocal relationship from ARDX graph: Reciprocal relationship from CAH graph: Reciprocal relationship from ARDX graph: Reciprocal relationship from CAH graph: Reciprocal relationship from ARDX gra… |
| BNS | The Bank of Nova Scotia | 72% | Reciprocal relationship from BNS graph: Reciprocal relationship from CAH graph: Reciprocal relationship from BNS graph: Reciprocal relationship from CAH graph: Reciprocal relationship from BNS graph:… |
| BNS | The Bank of Nova Scotia | 72% | . Each of Seller, the Servicer, each Purchaser, each Managing Agent and the Agent agrees that each Conduit shall be liable for any claims that such party may have against such Conduit only to the ext… |
| CHRS | Coherus Oncology, Inc. | 72% | Reciprocal relationship from CHRS graph: Reciprocal relationship from CAH graph: Reciprocal relationship from CHRS graph: Reciprocal relationship from CAH graph: Reciprocal relationship from CHRS gra… |
| COR | Cencora, Inc. | 72% | Reciprocal relationship from COR graph: Reciprocal relationship from CAH graph: Reciprocal relationship from COR graph: . We will continue to invest in advanced information systems and automated ware… |
| EMMA | Emmaus Life Sciences, Inc. | 72% | Reciprocal relationship from EMMA graph: Reciprocal relationship from CAH graph: Reciprocal relationship from EMMA graph: Reciprocal relationship from CAH graph: Reciprocal relationship from EMMA gra… |
| GILD | Gilead Sciences, Inc. | 72% | Reciprocal relationship from GILD graph: erns of our non-retail customers. In light of the budget crises faced by many European countries, we have observed variations in purchasing patterns induced b… |
| HROW | Harrow, Inc. | 72% | Reciprocal relationship from HROW graph: uct relative to alternative products, the availability of third-party reimbursement, the success of sales and marketing efforts, brand recognition and the ava… |
| MCK | McKesson Corporation | 72% | Reciprocal relationship from MCK graph: Reciprocal relationship from CAH graph: Reciprocal relationship from MCK graph: Reciprocal relationship from CAH graph: Reciprocal relationship from MCK graph:… |
| MRK | Merck & Co., Inc. | 72% | Reciprocal relationship from MRK graph: Reciprocal relationship from CAH graph: Reciprocal relationship from MRK graph: Reciprocal relationship from CAH graph: Reciprocal relationship from MRK graph:… |
| PCRX | Pacira BioSciences, Inc. | 72% | Reciprocal relationship from PCRX graph: Reciprocal relationship from CAH graph: Reciprocal relationship from PCRX graph: s of the partnership, LG Chem has the exclusive rights to commercialize EXPAR… |
| SNYNF | Sanofi | 72% | Reciprocal relationship from SNYNF graph: Reciprocal relationship from CAH graph: . This growth is driven by robust demand across specialty distribution, the expansion of the company’s MSO platforms … |
| SNYNF | Sanofi | 72% | . This growth is driven by robust demand across specialty distribution, the expansion of the company’s MSO platforms and over 30% anticipated revenue growth in BioPharma Solutions in fiscal 2026. In … |
| SUPN | Supernus Pharmaceuticals, Inc. | 72% | Reciprocal relationship from SUPN graph: Reciprocal relationship from CAH graph: Reciprocal relationship from SUPN graph: could be harmed. The majority of our product sales are to pharmaceutical whol… |
| ADVANCED-DIABETES-SUPPLY-GROUP | ADVANCED-DIABETES-SUPPLY-GROUP | 62% | selling expenses and, in annual reporting periods, an entity's definition of selling expenses. This guidance will be effective for us in fiscal 2028 Form 10-K and should be applied on a prospective b… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| CAH-DEBT | Debt stack $2.8B | 90% | Market cache reports total debt of $2.8B. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| CAH-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC | VANGUARD CAPITAL MANAGEMENT LLC | 90% | 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 1434 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| HCSG | Healthcare Services Group, Inc. | 100.00 | 1 | ['customer'] |
| BNTX | BioNTech SE | 100.00 | 2 | |
| DYN | Dyne Therapeutics, Inc. | 100.00 | 2 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 100.00 | 2 | |
| SDGR | Schrödinger, Inc. | 100.00 | 2 | |
| ARDX | Ardelyx, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| CVSI | CV Sciences, Inc. | 100.00 | 2 | |
| CHRS | Coherus Oncology, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| AMPH | Amphastar Pharmaceuticals, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| EMMA | Emmaus Life Sciences, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| BORAY | Bora Pharmaceuticals Co., Ltd. | 100.00 | 2 | |
| CABA | Cabaletta Bio, Inc. | 100.00 | 2 | |
| ADCT | ADC Therapeutics SA | 100.00 | 1 | ['supplier'] |
| CLH | Clean Harbors, Inc. | 100.00 | 2 | |
| BNS | The Bank of Nova Scotia | 100.00 | 1 | ['customer'] |
| AVIR | Atea Pharmaceuticals, Inc. | 100.00 | 2 | |
| AZN | AstraZeneca PLC | 100.00 | 2 | |
| COR | Cencora, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| CVS | CVS Health Corporation | 100.00 | 1 | ['customer', 'supplier'] |
| CRIS | Curis, Inc. | 100.00 | 2 |